buprenorphine hydrochloride, naloxone hydrochloride

FDA Drug Profile — Suboxone

buprenorphine hydrochloride, naloxone hydrochloride is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Suboxone. Available dosage form: film, soluble.

Drug details

Generic Name
buprenorphine hydrochloride, naloxone hydrochloride
Brand Names
Suboxone
Application Number
NDA022410
Sponsor
INDIVIOR INC.
NDC Codes
4
Dosage Forms
FILM, SOLUBLE
Routes
BUCCAL, SUBLINGUAL
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE SUBOXONE sublingual film is indicated for treatment of opioid dependence. SUBOXONE sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support. SUBOXONE® sublingual film contains buprenorphine, a partial‐opioid agonist, and naloxone, an opioid antagonist, and is indicated for treatment of opioid dependence. ( 1 ) SUBOXONE sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.